Low-fat high-fiber diet decreased serum and urine androgens in men

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 6, 2005, Pages 3550-3559

  Wang, Christina ^a   Catlin, Don H ^b   Starcevic, Borislav ^b   Heber, David ^c   Ambler, Christie ^a   Berman, Nancy ^a   Lucas, Geraldine ^a   Leung, Andrew ^a   Schramm, Kathy ^b   Lee, Paul W N ^a   Hull, Laura ^a   Swerdloff, Ronald S ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; ESTRADIOL; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ANDROGEN METABOLISM; ARTICLE; BODY WEIGHT; CALORIC INTAKE; DIET; ENERGY EXPENDITURE; ESTRADIOL BLOOD LEVEL; FAT INTAKE; HEMOCONCENTRATION; HIGH FIBER DIET; HORMONE BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; LOW FAT DIET; MALE; METABOLIC CLEARANCE RATE; NORMAL HUMAN; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE SYNTHESIS; URINARY EXCRETION; URINE LEVEL; VALIDATION PROCESS; BLOOD; BODY MASS; CLINICAL TRIAL; DIETARY FIBER; MIDDLE AGED; REFERENCE VALUE; URINE;

ANDROGENS; BODY MASS INDEX; BODY WEIGHT; DIET, FAT-RESTRICTED; DIETARY FIBER; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 21244483167     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1530     Document Type: Article

References (81)

1. Rose DP 1996 The mechanistic rationale in support of dietary cancer prevention. Prev Med 25:34-37
2. Ross RK, Henderson BE 1994 Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 86:252-254
3. Fair WR, Fleshner NE, Heston W 1997 Cancer of the prostate: a nutritional disease? Urology 50:840-848
4. Clinton SK, Giovannucci E 1998 Diet, nutrition, and prostate cancer. Annu Rev Nutr 18:413-440
5. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW 1995 Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87:652-661
6. Hayes RB, Ziegler RG, Gridley G, Swanson C, Greenberg RS, Swanson GM, Schoenberg JB, Silverman DT, Brown LM, Pottern LM, Liff J, Schwartz AG, Fraumeni JF, Hoover RN 1999 Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev 8:25-34
7. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, Willett WC 1993 A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85:1571-1579
8. Gann H, Hennekens CH, Ma J, Longcope C, Stampfer MJ 1996 Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88:1118-1126
9. Schuurman AG, van den Brandt PA, Dorant E, Brants HA, Goldbohm RA 1999 Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study. Cancer 86:1019-1027
10. Schroder FH 1990 Androgens and carcinoma of the prostate. In: Nieschlag E, Behre HM, eds. Testosterone: action, deficiency, substitution. Berlin: Springer Verlag; 243-260
11. van Steenbrugge GJ, Schroder FH 1988 Androgen-dependent human prostate cancer in nude mice The PC-82 tumor model. Am J Clin Oncol 11(Suppl 2):S8-S12
12. McConnell JD 1991 Physiologic basis of endocrine therapy for prostatic cancer. Urol Clin North Am 18:1-13
13. Bosland MC 2000 The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 27:39-66
14. Hsing AW 2001 Hormones and prostate cancer: what's next? Epidemiol Rev 23:42-58
15. Jackson MA, Kovi J, Heshmat MY, Ogunmuyiwa TA, Jones GW, Williams AO, Christian EC, Nkposong EO, Rao MS, Jackson AG, Ahluwalia B 1980 Characterization of prostatic carcinoma among blacks: a comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington DC. Prostate 1:185-205
16. Ahluwalia B, Jackson MA, Jones GW, Williams AO, Rao MS, Rajguru S 1981 Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations. Cancer 48:2267-2273
17. Bartsch W, Steins P, Becker H 1977 Hormone blood levels in patients with prostatic carcinoma and their relation to the type of carcinoma growth differentiation. Eur Urol 3:47-52
18. de Jong FH, Oishi K, Hayes RB, Bogdanowicz JF, Raatgever JW, van der Maas PJ, Yoshida O, Schroeder FH 1991 Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study. Cancer Res 51:3445-3450
19. Kreig M, Bartsch W, Janssen W, Voight KD 1979 A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate. J Steroid Biochem 10:93-111
20. Klein H, Bressel M, Kastendieck H, Voigt KD 1988 Androgens, adrenal androgen precursors, and their metabolism in untreated primary tumors and lymph node metastases of human prostatic cancer. Am J Clin Oncol 11(Suppl 2):S30-S36
21. Meikle AW, Smith JA, Stringham JD 1989 Estradiol and testosterone metabolism and production in men with prostatic cancer. J Steroid Biochem 33:19-24
22. Hulka BS, Hammond JE, DiFerdinando G, Mickey DD, Fried FA, Checkoway H, Stumpf WE, Beckman WCJ, Clark TD 1987 Serum hormone levels among patients with prostatic carcinoma or benign prostatic hyperplasia and clinic controls. Prostate 11:171-182
23. Nomura A, Heilbrun LK, Stemmermann GN, Judd HL 1988 Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res 48:3515-3517
24. Hsing AW, Comstock GW 1993 Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev 2:27-32
25. Barrett-Connor E, Garland C, McPhillips JB, Khaw KT, Wingard DL 1990 A prospective, population-based study of androstenedione, estrogens, and prostatic cancer. Cancer Res 50:169-173
26. Andersson SO, Adami HO, Bergstrom R, Wide L 1993 Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer-a populationbased case-control study. Br J Cancer 68:97-102
27. Eaton NE, Reeves GK, Appleby PN, Key TJ 1999 Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies. Br J Cancer 80:930-934
28. Kaaks R, Lukanova A, Sommersberg B 2000 Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis 3:157-172
29. Heikkila R, Aho K, Heliovaara M, Hakama M, Marniemi J, Reunanen A, Knekt P 1999 Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study. Cancer 86:312-315
30. Gustafsson O, Norming U, Gustafsson S, Eneroth P, Astrom G, Nyman CR 1996 Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population. Br J Urol 77:433-440
31. Shaneyfelt T, Husein R, Bubley G, Mantzoros CS 2000 Hormonal predictors of prostate cancer: a meta-analysis. J Clin Oncol 18:847-853
32. Rose DP, Laakso K, Sotarauta M, Wynder EL 1984 Hormone levels in prostatic fluid from healthy Finns and prostate cancer patients. Eur J Cancer Clin Oncol 20:1317-1319
33. Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS, Santen RJ 1991 Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab 72:1242-1248
34. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC, Henderson BE 1992 5-α-Reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339:887-889
35. Santner SJ, Albertson B, Zhang GY, Zhang GH, Santulli M, Wang C, Demers LM, Shackleton C, Santen RJ 1998 Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects. J Clin Endocrinol Metab 83:2104-2109
36. Jin B, Turner L, Zhou Z, Zhou EL, Handelsman DJ 1999 Ethnicity and migration as determinants of human prostate size. J Clin Endocrinol Metab 84:3613-3619
37. Wang C, Catlin DH, Starcevic B, Leung A, DiStefano E, Lucas G, Hull L, Swerdloff RS 2004 Testosterone metabolic clearance and production rates determined by stable isotope dilution/tandem mass spectrometry in normal men: influence of ethnicity and age. J Clin Endocrinol Metab 89:2936-2941
38. Wolfe RR 1992 Radioactive and stable isotope tracers in biomedics. 2nd ed. New York: Wiley-Liss
39. Goran MI, Poehlman ET 1992 Total energy expenditure and energy requirements in healthy elderly persons. Metabolism 41:744-753
40. Wang C, Iranmanesh A, Berman N, McDonald V, Steiner B, Ziel F, Faulkner SM, Dudley RE, Veldhuis JD, Swerdloff RS 1998 Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men-a clinical research center study. J Clin Endocrinol Metab 83:2749-2757
41. Swerdloff RS, Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Longstreth J, Berman N 2000 Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 85:4500-4510
42. Catlin DH, Kammerer RC, Hatton CK, Sekera MH, Merdink JL 1987 Analytical chemistry at the Games of the XXIIIrd Olympiad in Los Angeles, 1984. Clin Chem 33:319-327
43. Catlin DH, Hatton CK, Starcevic SH 1997 Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athletes' urine. Clin Chem 43:1280-1288
44. Catlin DH, Starcevic B 1991 HPLC method for the assay of creatinine in urine. J Liq Chromatogr 14:2399-2408
45. Starcevic B, DiStefano E, Wang C, Catlin DH 2003 Liquid chromatographytandem mass spectrometry assay for human serum testosterone and trideuterated testosterone. J Chromatogr B Analyt Technol Biomed Life Sci 792:197-204
46. Gelpi E 1995 Biomedical and biochemical applications of liquid chromatography-mass spectrometry. J Chromatogr A 703:59-80
47. Lepage G, Roy CC 1986 Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27:114-120
48. Epler KS, Ziegler RG, Craft NE 1993 Liquid chromatographic method for the determination of carotenoids, retinoids, and tocopherols in human serum and in food. J Chromatgr 619:37-48
49. Hamalainen E, Adlercreutz H, Puska P, Pietinen P 1984 Diet and serum sex hormones in healthy men. J Steroid Biochem 20:459-464
50. Rosenthal MB, Barnard RJ, Rose DP, Inkeles S, Hall J, Pritikin N 1985 Effects of a high-complex-carbohydrate, low-fat, low-cholesterol diet on levels of serum lipids and estradiol. Am J Med 78:23-27
51. Taylor HL, Jacobs Jr DR, Schucker B, Knudsen J, Leon AS, DeBacker G 1978 A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 31:741-755
52. Hill P, Wynder EL, Garbaczewski L, Garnes H, Walker AR 1979 Diet and urinary steroids in black and white North American men and black South African men. Cancer Res 39:5101-5105
53. Deslypere JP, Vermeulen A 1984 Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity. J Clin Endocrinol Metab 59:955-962
54. Belanger A, Locong A, Noel C, Cusan L, Dupont A, Prevost J, Caron S, Sevigny J 1989 Influence of diet on plasma steroids and sex hormone-binding globulin levels in adult men. J Steroid Biochem 32:829-833
55. Key TJ, Roe L, Thorogood M, Moore JW, Clark GM, Wang DY 1990 Testosterone, sex hormone-binding globulin, calculated free testosterone, and oestradiol in male vegans and omnivores. Br J Nutr 64:111-119
56. Dorgan JF, Judd JT, Longcope C, Brown C, Schatzkin A, Clevidence BA, Campbell WS, Nair PP, Franz C, Kahle L, Taylor PR 1996 Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr 64:850-855
57. Adlercreutz H, Markkanen H, Watanabe S 1993 Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342:1209-1210
58. Longcope C, Feldman HA, McKinlay JB, Araujo AB 2000 Diet and sex hormone-binding globulin. J Clin Endocrinol Metab 85:293-296
59. Bagga D, Capone S, Wang HJ, Heber D, Lill M, Chap L, Glaspy JA 1997 Dietary modulation of -3/ -6 polyunsaturated fatty acid ratios in patients with breast cancer. J Natl Cancer Inst 89:1123-1131
60. Liang T, Liao S 1992 Inhibition of steroid 5-reductase by specific aliphatic unsaturated fatty acids. Biochem J 285(Pt 2):557-562
61. Meikle AW, Stringham JD, Woodward MG, McMurry MP 1990 Effects of a fat-containing meal on sex hormones in men. Metabolism 39:943-946
62. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Willkinson P, Hennekens CH, Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566
63. Harman SM, Metter EJ, Blackman MR, Landis PK, Carter HB 2000 Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer. J Clin Endocrinol Metab 85:4258-4265
64. Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Fraumeni Jr JF, Hsing AW 2002 Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate 52:98-105
65. Stattin P, Bylund A, Rinaldi S, Biessy C, Dechaud H, Stenman UH, Egevad L, Riboli E, Hallmans G, Kaaks R 2000 Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92:1910-1917
66. Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D 2003 Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men. Cancer Res 63:3991-3994
67. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano JM, Pollak M, Giovannucci E 2002 Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 94:1099-1106
68. Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Fraumeni Jr JF, Hsing AW 2002 Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate 52:98-105
69. Li L, Yu H, Schumacher F, Casey G, Witte JS 2003 Relation of serum insulinlike growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States). Cancer Causes Control 14:721-726
70. Oliver SE, Gunnell D, Donovan J, Peters TJ, Persad R, Gillatt D, Pearce A, Neal DE, Hamdy FC, Holly J 2004 Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. Int J Cancer 108:887-892
71. Ali O, Cohen P, Lee KW 2003 Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule. Horm Metab Res 35:726-733
72. Ngo TH, Barnard RJ, Leung PS, Cohen P, Aronson WJ 2003 Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival. Endocrinology 144:2319-2324
73. Thissen JP, Ketelslegers JM, Underwood LE 1994 Nutritional regulation of the insulin-like growth factors. Endocr Rev 15:80-101
74. Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB, Willett WC 2003 Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 12:84-89
75. Allen NE, Appleby PN, Davey GK, Key TJ 2000 Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer 83:95-97
76. Darling-Raedeke M, Thornton Jr WH, MacDonald RS 1998 Growth hormone and IGF-I plasma concentrations and macronutrient intake measured in a free-living elderly population during a one-year period. J Am Coll Nutr 17:392-397
77. Mucci LA, Tamimi R, Lagiou P, Trichopoulou A, Benetou V, Spanos E, Trichopoulos D 2001 Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int 87:814-820
78. Signorello LB, Kuper H, Lagiou P, Wuu J, Mucci LA, Trichopoulos D, Adami HO2000 Lifestyle factors and insulin-like growth factor 1 levels among elderly men. Eur J Cancer Prev 9:173-178
79. Holmes MD, Pollak MN, Willett WC, Hankinson SE 2002 Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11:852-861
80. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y, Mantzoros CS 1999 Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. J Clin Oncol 17:3291-3298
81. Gunnell D, Oliver SE, Peters TJ, Donovan JL, Persad R, Maynard M, Gillatt D, Pearce A, Hamdy FC, Neal DE, Holly JM 2003 Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer 88:1682-1686